Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 76
Filter
Add more filters

Country/Region as subject
Publication year range
1.
Ophthalmology ; 2024 Mar 27.
Article in English | MEDLINE | ID: mdl-38552677

ABSTRACT

PURPOSE: To report use trends of plasma exchange (PLEX) as well as sociodemographic and medical comorbidities associated with PLEX in the United States. DESIGN: Retrospective cross-sectional study. PARTICIPANTS: Adult patients (≥ 18 years) admitted for inpatient hospitalization with a primary diagnosis of optic neuritis (ON). METHODS: Data from the National Inpatient Sample database was compiled to assess PLEX use rates between 2000 and 2020. The cohorts of patients receiving PLEX versus not receiving PLEX were analyzed between quarter 4 of 2015 through 2020 (International Classification of Diseases, Tenth Revision [ICD-10], only) for patient sociodemographic variables, medical diagnoses, insurance types, hospital characteristics, cause of disease, time to therapy, length of stay (LOS), and total charges incurred. MAIN OUTCOME MEASURES: Incidence of ON, incidence of PLEX, demographics, diagnoses associated with PLEX therapy, total charges, and LOS. RESULTS: From 2000 through 2020, 11 209 patients hospitalized with a primary diagnosis of ON were identified, with a significant majority managed at urban teaching hospitals. Use of PLEX increased steadily over 2 decades from 0.63% to 5.46%. Use was greatest in the western United States and least in the eastern United States. In the subset of ICD-10 cases, 3215 patients were identified. The median time to therapy of PLEX was 1 day after admission, and PLEX use was highest in patients with neuromyelitis optica spectrum disorder (NMOSD) (21.21%) and lowest in multiple sclerosis-associated ON (3.80%). Use of PLEX was associated with significantly longer LOS and higher total charges incurred. Medical comorbidities associated with PLEX included adverse reaction to glucocorticoids (adjusted odds ratio [aOR], 31.50), hemiplegia (aOR, 28.48), neuralgia (aOR, 4.81), optic atrophy (aOR, 3.74), paralytic strabismus (aOR, 2.36), and psoriasis (aOR, 1.76). CONCLUSIONS: Over the last 2 decades in the United States, PLEX therapy for ON has increased, with the highest use in the western United States and for patients with the diagnosis NMOSD ON. FINANCIAL DISCLOSURE(S): The author(s) have no proprietary or commercial interest in any materials discussed in this article.

2.
BMC Ophthalmol ; 23(1): 40, 2023 Jan 27.
Article in English | MEDLINE | ID: mdl-36707790

ABSTRACT

BACKGROUND: To investigate the efficacy of injecting suprachoroidal triamcinolone acetonide (SCTA) plus intravitreal bevacizumab (IVB) into patients with center-involving diabetic macular edema (CI-DME). METHODS: In this phase 2/3 randomized controlled pilot trial, sixty-six eyes with CI-DME and best-corrected visual acuity (BCVA) of at most 20/50 Snellen chart were randomly assigned into two groups. Monotherapy arm received sham injection plus 3 monthly IVB doses and combination arm received a single dose of SCTA and 3 monthly IVB doses. The mean improvements in BCVA and Central subfield thickness (CST), over the three-month was considered the main efficacy outcomes. RESULTS: The mean BCVA improvements were obtained respectively as - 0.20 ± 0.20 log [minimum angle of resolution (MAR)] (P = 0.004) and 0.37 ± 0.24 log MAR (P < 0.001) in monotherapy and combination arms [between-group analysis (P = 0.014)]. Significant improvements were also observed in CST (P = 0.019) in the combination arm compared to the other. No adverse events (elevated intraocular pressure, cataract) were observed in any of the study arms. CONCLUSION: Significant improvements in BCVA and retinal anatomical outcomes demonstrated the additive effects of SCTA to those of anti-vascular endothelial growth factors with no short-term side effects and this combination appears to be a promising option in the management of patients with CI-DME. TRIAL REGISTRATION: The trial was registered in Iranian Registry of Clinical Trials (IRCT20200314046761N1).


Subject(s)
Diabetes Mellitus , Diabetic Retinopathy , Macular Edema , Humans , Bevacizumab/therapeutic use , Triamcinolone Acetonide , Macular Edema/diagnosis , Macular Edema/drug therapy , Macular Edema/etiology , Pilot Projects , Diabetic Retinopathy/complications , Diabetic Retinopathy/diagnosis , Diabetic Retinopathy/drug therapy , Glucocorticoids , Iran , Angiogenesis Inhibitors/therapeutic use , Intravitreal Injections , Treatment Outcome
3.
BMC Ophthalmol ; 22(1): 427, 2022 Nov 09.
Article in English | MEDLINE | ID: mdl-36348282

ABSTRACT

BACKGROUND: To investigate the possible association of different pattern of diabetic retinopathy (DR) on corneal endothelium cells in type 2 diabetes mellitus patients. METHODS: In this descriptive-analytical cross-sectional study, corneal endothelium parameters including endothelial cell density (ECD), average cell size (AVG), coefficient of variation in cell size (CV), and hexagonality (Hex) were evaluated by non-contact specular microscopy. RESULTS: One hundred and thirty-four eyes of 134 diabetic patients including 77 females (57.5%) with a mean age of 61.03 ± 8.08 years were enrolled. The overall corneal parameters in diabetic patients with and without retinopathy were not significantly different (P > 0.05). There is a significant relationship between CV and the duration of the disease with age variable control (B = 0.369, p-value < 0.001). CONCLUSIONS: Corneal endothelial parameters were not associated with DM in patients without and with DR. There is a significant relationship between CV and the duration of the disease with age variable control.


Subject(s)
Diabetes Mellitus, Type 2 , Diabetic Retinopathy , Female , Humans , Middle Aged , Aged , Endothelium, Corneal , Cross-Sectional Studies , Diabetes Mellitus, Type 2/complications , Cell Count
4.
Ophthalmic Plast Reconstr Surg ; 38(1): e2-e6, 2022.
Article in English | MEDLINE | ID: mdl-34431823

ABSTRACT

An 84-year-old man presented with a localized, firm, tender mass over the right lacrimal sac. He had a history of acute dacryocystitis in the same eye 6 months before presentation, which resolved with antibiotics followed by uneventful dacryocystorhinostomy. At repeat presentation, the patient underwent orbital imaging and excisional biopsy of the lesion. Histologic studies revealed a small cell neuroendocrine carcinoma. The patient was subsequently treated with chemotherapy and radiation. Although there are rare reports of small cell neuroendocrine carcinoma originating in the sino-orbital-lacrimal region, this is the first report of tumor presentation with acute dacryocystitis in a patient with prior dacryocystorhinostomy.


Subject(s)
Carcinoma, Neuroendocrine , Dacryocystitis , Dacryocystorhinostomy , Lacrimal Apparatus Diseases , Nasolacrimal Duct , Aged, 80 and over , Carcinoma, Neuroendocrine/diagnosis , Dacryocystitis/diagnosis , Dacryocystitis/etiology , Dacryocystitis/surgery , Humans , Lacrimal Apparatus Diseases/surgery , Male
5.
J Neuroophthalmol ; 41(2): 176-193, 2021 Jun 01.
Article in English | MEDLINE | ID: mdl-33999889

ABSTRACT

ABSTRACT: This review of disorders of the fourth cranial nerve includes discussion on anatomy, examination techniques, congenital and acquired etiologies, differential diagnosis, and management options. The findings of the superior oblique muscle on orbital MRI in patients with fourth nerve palsy have had a major impact on our understanding of this cranial neuropathy. In addition, briefly reviewed are rare disorders of the fourth nerve: superior oblique myokymia, Brown syndrome, and ocular neuromyotonia. It behooves the clinician to have a clear understanding of the role that the fourth cranial nerve plays in a variety of neuro-ophthalmic conditions.


Subject(s)
Cranial Nerve Diseases/diagnosis , Ocular Motility Disorders/etiology , Oculomotor Muscles/innervation , Trochlear Nerve/diagnostic imaging , Cranial Nerve Diseases/complications , Humans , Magnetic Resonance Imaging , Ocular Motility Disorders/diagnosis , Oculomotor Muscles/diagnostic imaging
6.
Ann Emerg Med ; 76(6): 801-803, 2020 12.
Article in English | MEDLINE | ID: mdl-32950279

ABSTRACT

Orbital compartment syndrome is a critical ophthalmic emergency that needs urgent diagnosis and treatment to prevent permanent vision loss caused by optic nerve compression or retinal ischemia. In this article, we present a child with orbital compartment syndrome caused by orbital emphysema as a result of a rare type of ocular trauma and introduce a simple technique to decompress the pressure. The patient was a 4-year-old boy who experienced a compressed air blast to his left eye. He presented to the emergency department with a frozen globe, tight orbit, and chemosis, without any evidence of globe rupture, conjunctival laceration, and orbital bone fracture. Computed tomographic scan demonstrated extensive subcutaneous, intraorbital, and intracranial emphysema. The pressure was immediately relieved under intravenous sedation by inserting a 27-gauge needle into the chemotic subconjunctival space at the lower lid fornix, followed by gentle manipulation of the globe to help the air escape through the needle. Compressed air injury is a rare type of orbital trauma, and this patient constituted the youngest case ever reported in the English literature, to our knowledge. Air decompression through the conjunctiva as described in this article is a useful technique that can be applied by emergency medicine specialists with special caution for patients with orbital compartment syndrome and orbital emphysema caused by compressed air injury.


Subject(s)
Compressed Air/adverse effects , Decompression/methods , Orbit/injuries , Subcutaneous Emphysema/therapy , Child, Preschool , Conjunctiva/surgery , Emergency Medicine/methods , Emergency Service, Hospital , Eye Injuries/complications , Humans , Male , Needles/adverse effects , Orbital Diseases/complications , Subcutaneous Emphysema/diagnostic imaging , Subcutaneous Emphysema/etiology , Tomography, X-Ray Computed/methods , Treatment Outcome
7.
Future Oncol ; 15(24): 2873-2885, 2019 Aug.
Article in English | MEDLINE | ID: mdl-31342783

ABSTRACT

Despite the numerous publications regarding the role of Epstein-Barr virus (EBV) in breast cancer development, the topic has still remained controversial. The aim of the meta-analysis was to estimate the overall prevalence of EBV in the breast cancer population, and to investigate the association between EBV and breast cancer risk. The overall prevalence of EBV was calculated 26.37% (95% CI: 22-31%) from the 44 included studies. Meta-analysis of 30 case-control studies showed that the pooled association between EBV and risk of breast cancer is odds ratio 4.74 (95% CI: 2.92-7.69; Z = 6.30; p < 0.0001). Our analyses indicate a strong statistical relationship between EBV infection and risk of breast cancer, suggesting a potential role of EBV infection in the development of breast cancer.


Subject(s)
Breast Neoplasms/etiology , Breast Neoplasms/virology , Epstein-Barr Virus Infections/complications , Herpesvirus 4, Human/pathogenicity , Case-Control Studies , Epstein-Barr Virus Infections/virology , Female , Humans , Odds Ratio , Prevalence
8.
Ophthalmologica ; 239(2-3): 159-166, 2018.
Article in English | MEDLINE | ID: mdl-29393260

ABSTRACT

PURPOSE: To evaluate the effects of intravitreal silicone oil (SO) on subfoveal choroidal thickness (SFCT). METHODS: A total of 60 patients with unilateral pseudophakic macula-off rhegmatogenous retinal detachment were treated with a three-port pars plana vitrectomy and a 5,700-cSt SO endo-tamponade and subsequent SO removal. SFCT was measured before and 3 months after SO removal. The main outcome measure was the difference between the SFCT of operated eyes and the fellow eyes. RESULTS: Before SO removal, the mean SFCT differences in group 1 (3-6 months' duration of SO), group 2 (6-9 months' duration of SO), and group 3 (9-18 months' duration of SO) were -14.8, -25.5, and -62.1 µm, respectively (p = 0.002, r = 0.398). Three months after SO removal, the mean SFCT differences in group 1, group 2, and group 3 were -13.4, -23.3, and -59.0 µm, respectively (p = 0.002, r = 0.393). CONCLUSION: SFCT decreased significantly in eyes with long-term (≥6 months) intravitreal SO tamponade. Choroidal thinning did not improve after SO removal.


Subject(s)
Choroid/pathology , Endotamponade/methods , Macula Lutea/pathology , Retinal Detachment/therapy , Silicone Oils/administration & dosage , Tomography, Optical Coherence/methods , Visual Acuity , Vitrectomy/methods , Female , Follow-Up Studies , Fovea Centralis , Humans , Intravitreal Injections , Male , Middle Aged , Retinal Detachment/diagnosis , Retinal Detachment/physiopathology , Retrospective Studies , Time Factors
11.
Ophthalmic Plast Reconstr Surg ; 34(5): e151-e153, 2018.
Article in English | MEDLINE | ID: mdl-29952933

ABSTRACT

A 5-year-old boy was accidentally injured by a compressed air blast to his right eye and developed periorbital and subconjunctival emphysema and proptosis subsequently. CT scan showed periorbital subcutaneous and intraorbital emphysema around the right eye, as well as intracranial and cervical emphysema without frank fractures in orbital bones. He was examined under sedation, and the subconjunctival air was aspirated. He was also prophylactically treated with topical and systemic antibiotics to prevent infection. Emphysema was resorbed entirely within 3 weeks. In conclusion, compressed air injury can occur in a child and manifest with orbital and periorbital emphysema without any detectable fracture and any clear entrance site and may need emergent management to save the vision or upper respiratory airways.


Subject(s)
Blast Injuries/complications , Compressed Air/adverse effects , Conjunctival Diseases/etiology , Eye Injuries, Penetrating/complications , Orbital Diseases/etiology , Subcutaneous Emphysema/etiology , Child, Preschool , Humans , Male
12.
Ophthalmic Plast Reconstr Surg ; 34(6): 575-578, 2018.
Article in English | MEDLINE | ID: mdl-29634604

ABSTRACT

PURPOSE: Conjunctival Müller's muscle resection (CMMR) is a posterior approach surgical technique to correct blepharoptosis. The purpose of this study is to compare patient-reported pain scores and surgical outcomes for patients who received 2 different anesthetic techniques during CMMR, frontal nerve block and subconjunctival injection. METHODS: A prospective randomized comparative clinical trial enrolled 33 CMMR subjects from one tertiary eye center. Patients undergoing unilateral CMMR were randomized to receive either frontal nerve block or subconjunctival injection. For patients undergoing bilateral CMMR, each side was randomized to one of the injection techniques. Upper eyelid margin reflex distance was measured and recorded for each eye before and after surgery. Patients' pain scores were quantified using the Wong Baker Pain Scale. Subjects quantified their pain during, immediately after, 12 and 24 hours after surgery. RESULTS: Twenty-four bilateral and 9 unilateral cases were enrolled in the study. Twenty-two (92%) subjects were female, and the mean patient age was 69 ± 12 years. The mean margin reflex distance was 1.1 mm preoperatively, which increased to 3.5 and 3.6 mm 2 months postoperatively in frontal nerve block and subconjunctival injection groups, respectively (p value <0.0001). Both paired and nonpaired analyses demonstrated no significant difference in the pain score reported by the patients or the surgical outcomes between the 2 anesthesia techniques at any time during or after the surgery. There were no anesthetic-related complications. CONCLUSION: There was no statistically significant difference in pain scores or surgical outcomes in patients receiving frontal nerve block compared with those receiving subconjunctival injection during CMMR surgery.


Subject(s)
Anesthesia/methods , Blepharoplasty/methods , Blepharoptosis/surgery , Injections, Intraocular/methods , Nerve Block/methods , Oculomotor Muscles/surgery , Adult , Aged , Aged, 80 and over , Anesthetics/administration & dosage , Female , Humans , Male , Middle Aged , Pain, Postoperative/prevention & control , Prospective Studies , Young Adult
13.
J Craniofac Surg ; 29(8): e790-e792, 2018 Nov.
Article in English | MEDLINE | ID: mdl-30277940

ABSTRACT

Cavernous hemangioma (CH) is the most common benign tumor of the orbit which can expand the bony orbit by gradual growth of a large tumor. In this article, the authors report a 28-year-old man presented with a longstanding unilateral proptosis secondary to a huge orbital CH which also caused optic disc deformation and bone erosions in the adjacent orbital walls. The optic disc deformities resolved after the tumor removal.


Subject(s)
Bone Diseases/etiology , Exophthalmos/etiology , Hemangioma, Cavernous/complications , Optic Nerve Diseases/etiology , Orbital Neoplasms/complications , Adult , Hemangioma, Cavernous/diagnostic imaging , Humans , Male , Optic Disk , Orbital Neoplasms/diagnostic imaging , Tomography, X-Ray Computed/adverse effects , Zygoma/diagnostic imaging
15.
J Neuroophthalmol ; 42(2): e527, 2022 06 01.
Article in English | MEDLINE | ID: mdl-35483087
16.
J Neuroophthalmol ; 42(4): e610, 2022 12 01.
Article in English | MEDLINE | ID: mdl-36394974
18.
Ophthalmic Plast Reconstr Surg ; 33(1): 27-30, 2017.
Article in English | MEDLINE | ID: mdl-26784551

ABSTRACT

PURPOSE: This study evaluated the efficacy of a new pushed monocanalicular silicone tube in reconstructing traumatic canalicular laceration. METHODS: This interventional case series enrolled 48 patients with a traumatic canalicular laceration. Patients with bicanalicular involvement were excluded. Canalicular repair was performed under an operating microscope and involved proximal end exploration of the canaliculus, stenting of the canaliculus with a 35-mm Masterka tube, and approximation of the lacerated canaliculi margins. After 6 months, anatomical and functional success rates were evaluated by diagnostic probing and by asking the patients (or their guardians) about tearing. RESULTS: The mean age of patients was 32.2 ± 21.2 years (1.5-75 years). Of the 48 patients included, 38 were males. Lower canaliculus was involved in 35 patients. Other ocular injuries were observed in 38 patients. The average interval between the surgery and Masterka removal was 12.2 ± 1.4 weeks (10-16 weeks). Early tube extrusion was observed in 3 patients. No significant complication was observed in this series. Anatomical and functional success rates were 87% and 100%, respectively. CONCLUSION: The results demonstrated that intubation of lacerated canaliculi with Masterka tube for canalicular repair was safe, effective, and simple with minimal complications.


Subject(s)
Eye Injuries, Penetrating/surgery , Intubation/instrumentation , Lacerations/surgery , Lacrimal Apparatus/injuries , Ophthalmologic Surgical Procedures/methods , Silicones , Stents , Adolescent , Adult , Aged , Child , Child, Preschool , Female , Humans , Infant , Lacrimal Apparatus/surgery , Male , Middle Aged , Plastic Surgery Procedures/methods , Young Adult
19.
Orbit ; 36(6): 448-451, 2017 Dec.
Article in English | MEDLINE | ID: mdl-28738175

ABSTRACT

Adenoid cystic carcinoma (ACC) of the lacrimal gland is an aggressive, malignant epithelial neoplasm. This tumor is rarely seen in adults and even less commonly seen in children and adolescents; thus, there have been no large studies to date describing the optimal treatment of this malignancy in the pediatric population. Here, we report a case of lacrimal gland ACC in a 14-year-old male treated with neoadjuvant intra-arterial chemotherapy followed by globe-sparing tumor resection and chemoradiation. At 2-year follow-up, he remains disease free without evidence of tumor recurrence.


Subject(s)
Carcinoma, Adenoid Cystic/pathology , Eye Neoplasms/pathology , Lacrimal Apparatus Diseases/pathology , Adolescent , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Carcinoma, Adenoid Cystic/diagnostic imaging , Carcinoma, Adenoid Cystic/therapy , Chemoradiotherapy , Combined Modality Therapy , Eye Neoplasms/diagnostic imaging , Eye Neoplasms/therapy , Humans , Infusions, Intra-Arterial , Lacrimal Apparatus Diseases/diagnostic imaging , Lacrimal Apparatus Diseases/therapy , Magnetic Resonance Imaging , Male , Neoadjuvant Therapy , Ophthalmologic Surgical Procedures , Positron-Emission Tomography
SELECTION OF CITATIONS
SEARCH DETAIL